Supply Chain

QuVa Pharma, a sterile compounding pharmaceutical company, recently acquired a new biotech facility in New Jersey.

What's worse: importing drug ingredients from a Chinese factory with known quality control issues or experiencing a shortage in the U.S. of crucial cancer drugs?

Here are the seven latest medical devices or drugs approved by the Food and Drug Administration.

The Food and Drug Administration recently approved ANI Pharmaceuticals' nilutamide tablets.

Abbott Park, Ill.-based Abbott Laboratories reported better-than-expected sales and profit for its second quarter, largely due to its sales in the medical device market, according to Reuters.

Patients feel entitled to drug discount programs when they're prescribed an expensive medication, according to a recent study.

Many pharmaceutical company executives are concerned over Brexit's impact on the European drug market, but Joe Jimenez, CEO Switzerland-based Novartis, doesn't fall in that category.

Government spending on compounded drugs has soared, causing federal investigators to question the possibility of fraud and overbilling, according to Kaiser Health News.

The amount of generic rivals available in relation to a brand name treatment can affect drug costs, according to a report in the Journal of the American Medical Association.

The Food and Drug Administration approved San Diego-based Arena Pharmaceuticals' Belviq XR extended-release tablets.